Cipla Global Established
+ Therapeutic Categories
+ Countries we export to, including the USA, UK, Australia and Germany.
Welcome to our world. A world where all South Africans have access to world class medicines at affordable prices. A world where affordable healthcare is a right, not a privilege. A world where the final measure of our success is a simple curve – the smile of health regained.
Advancing Healthcare For All
To become the preferred partner in medicine
- Respect and Pride
- Passion and Integrity
- Freedom to Succeed
- Service Excellence
- Social Responsibility
About Cipla SA
Cipla Medpro, 100%-owned by Cipla India, is one of the country’s leading pharmaceutical companies that produces world class medicines at affordable prices. Today the company is one of the largest pharmaceutical companies in South Africa by volume and third largest by value.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally.
Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla’s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001.
Cipla’s research and development focuses on developing innovative products and drug delivery systems.
- Cipla Medpro was founded 18 years ago.
- Today Cipla Medpro is the third largest generic medicines company in South Africa by value & volume.
- The company was the first in South Africa to launch a three in one ARV combination of a first line regimen (Triomune) in 2006.